| Literature DB >> 29792233 |
Shun-Xian Zhang1,2, Yong-Ming Zhou3, Li-Guang Tian4,5, Jia-Xu Chen4,5, Rita Tinoco-Torres6, Emmanuel Serrano7, Shi-Zhu Li4,5, Shao-Hong Chen4,5, Lin Ai4,5, Jun-Hu Chen4,5, Shang Xia4,5, Yan Lu4,5, Shan Lv4,5, Xue-Jiao Teng4,5, Wen Xu3, Wen-Peng Gu3, Si-Tang Gong2, Xiao-Nong Zhou8,9, Lan-Lan Geng10, Wei Hu11,12,13.
Abstract
BACKGROUND: Bacterial diarrhea is one of the most common causes for medical consultations, mortality and morbidity in the world. Diarrheagenic Escherichia coli (DEC) and non-typhoidal Salmonella (NTS) are major intestinal pathogens in developing countries, and the indiscriminate use of antibiotics has greatly contributed to resistant strains. Hence, the aim of the present study is to identify the antimicrobial resistance patterns and the molecular characteristics of DEC and NTS in southwest, China.Entities:
Keywords: Enterobacterial infections; Fingerprint typing; Gastroenteritis; Kunming; Yunnan
Mesh:
Substances:
Year: 2018 PMID: 29792233 PMCID: PMC5964730 DOI: 10.1186/s40249-018-0427-2
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 4.520
Performance standards for diarrheagenic Escherichia coli and non-typhoidal Salmonella to antimicrobial susceptibility testing conducted in the study
| Antibiotics | Resistant (cm) | Intermediate (cm) | Susceptible (cm) |
|---|---|---|---|
| AMP | ≤13 | 14–16 | ≥17 |
| AMC | ≤13 | 14–17 | ≥18 |
| CEP | ≤14 | 15–17 | ≥18 |
| CTX | ≤22 | 23–25 | ≥26 |
| GEN | ≤13 | 13–14 | ≥15 |
| NAL | ≤13 | 14–18 | ≥19 |
| CIP | ≤11 | 16–20 | ≥21 |
| TCY | ≤12 | 12–14 | ≥15 |
| REP | ≤14 | 15–16 | ≥17 |
| SXT | ≤10 | 11–15 | ≥16 |
Notes: 1: AMP Ampicillin, AMC Amoxicillin and Clavulafiate, CEP Cephalothin, CTX Cefotaxime, GEN Gentamicin, NAL Nalidixic acid, CIP Ciprofloxacin, TCY Tetracycline, REP Rifampicin, SXT Sulfamethoxazole–Trimethoprim.2: Performance standards for antimicrobial susceptibility testing conducted in the study was complied with the twenty–third informational supplement from clinical and laboratory standards institute (CLSI). 3: Centimeter (cm), Resistant (R), Intermediate (I), Susceptible (S)
The resistance of subtype of diarrheagenic Escherichia coli and non-typhoidal Salmonella isolated from diarrhea cases
| Antibiotics | Classification | DEC ( | NTS ( | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| DEC | EAEC | EPEC | EIEC | ETEC | NTS | Other | ||||
| AMP | Resistant | 100 (78.74) | 49 (81.67) | 46 (75.41) | 4 (80.00) | 1 (100.00) | 32 (76.19) | 21 (100.00) | 8 (66.67) | 3 (33.33) |
| Intermediate | 3 (2.36) | 1 (1.67) | 1 (1.64) | 1 (20.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| Susceptible | 24 (18.90) | 10 (16.67) | 14 (22.95) | 0 (0.00) | 0 (0.00) | 10 (23.81) | 0 (0.00) | 4 (33.33) | 6 (66.67) | |
| AMC | Resistant | 47 (37.01) | 19 (31.67) | 26 (42.62) | 2 (40.00) | 0 (0.00) | 6 (14.29) | 6 (28.57) | 0 (0.00) | 0 (0.00) |
| Intermediate | 10 (7.87) | 7 (11.67) | 3 (4.92) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| Susceptible | 70 (55.12) | 34 (56.67) | 32 (52.46) | 3 (60.00) | 1 (100.00) | 36 (85.71) | 15 (71.43) | 12 (100.00) | 9 (100.00) | |
| CEP | Resistant | 38 (29.92) | 18 (30.00) | 17 (27.87) | 3 (60.00) | 0 (0.00) | 5 (11.90) | 4 (19.05) | 1 (8.33) | 0 (0.00) |
| Intermediate | 11 (8.66) | 8 (13.33) | 3 (4.92) | 0 (0.00) | 0 (0.00) | 4 (9.52) | 2 (9.52) | 2 (16.67) | 0 (0.00) | |
| Susceptible | 78 (61.42) | 34 (56.67) | 41 (67.21) | 2 (40.00) | 1 (100.00) | 33 (78.57) | 15 (71.43) | 9 (75.00) | 9 (100.00) | |
| CTX | Resistant | 23 (18.11) | 9 (15.00) | 12 (19.67) | 2 (40.00) | 0 (0.00) | 4 (9.52) | 4 (19.05) | 0 (0.00) | 0 (0.00) |
| Intermediate | 4 (3.15) | 2 (3.33) | 2 (3.28) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| Susceptible | 100 (78.74) | 49 (81.67) | 47 (77.05) | 3 (60.00) | 1 (100.00) | 38 (90.48) | 17 (80.95) | 12 (100.00) | 9 (100.00) | |
| GEN | Resistant | 39 (30.71) | 25 (41.67) | 13 (21.31) | 1 (20.00) | 0 (0.00) | 5 (11.90) | 2 (9.52) | 2 (16.67) | 1 (11.11) |
| Intermediate | 3 (2.36) | 2 (3.33) | 1 (1.64) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| Susceptible | 85 (66.93) | 33 (55.00) | 47 (77.05) | 4 (80.00) | 1 (100.00) | 37 (88.10) | 19 (90.48) | 10 (83.33) | 8 (88.89) | |
| NAL | Resistant | 65 (51.18) | 38 (63.33) | 25 (40.98) | 2 (40.00) | 0 (0.00) | 28 (66.67) | 19 (90.48) | 7 (58.33) | 2 (22.22) |
| Intermediate | 7 (5.51) | 1 (1.67) | 5 (8.20) | 0 (0.00) | 1 (100.00) | 4 (9.52) | 2 (9.52) | 2 (16.67) | 0 (0.00) | |
| Susceptible | 55 (43.31) | 21 (35.00) | 31 (50.82) | 3 (60.00) | 0 (0.00) | 10 (23.81) | 0 (0.00) | 3 (25.00) | 7 (77.78) | |
| CIP | Resistant | 7 (5.51) | 4 (6.67) | 3 (4.92) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
| Intermediate | 7 (5.51) | 1 (1.67) | 4 (6.56) | 2 (40.00) | 0 (0.00) | 4 (9.52) | 1 (4.76) | 2 (16.67) | 1 (11.11) | |
| Susceptible | 113 (88.98) | 55 (91.67) | 54 (88.52) | 3 (60.00) | 1 (100.00) | 38 (90.84) | 20 (95.24) | 10 (83.33) | 8 (88.89) | |
| TCY | Resistant | 88 (69.29) | 36 (60.00) | 48 (78.69) | 3 (60.00) | 1 (100.00) | 21 (50.00) | 10 (47.62) | 9 (75.00) | 2 (22.22) |
| Intermediate | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| Susceptible | 39 (30.71) | 24 (40.00) | 13 (21.31) | 2 (40.00) | 0 (0.00) | 21 (50.00) | 11 (52.38) | 3 (25.00) | 7 (77.78) | |
| REP | Resistant | 124 (97.64) | 60 (100.00) | 58 (95.08) | 5 (100.00) | 1 (100.00) | 42 (100.00) | 21 (100.00) | 12 (100.00) | 9 (100.00) |
| Intermediate | 1 (0.79) | 0 (0.00) | 1 (1.64) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| Susceptible | 2 (1.57) | 0 (0.00) | 2 (3.28) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| SXT | Resistant | 79 (62.20) | 40 (66.67) | 35 (57.38) | 3 (60.00) | 1 (100.00) | 11 (26.19) | 6 (28.57) | 3 (25.00) | 2 (22.22) |
| Intermediate | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 5 (11.90) | 3 (14.29) | 2 (16.67) | 0 (0.00) | |
| Susceptible | 48 (37.80) | 20 (33.33) | 26 (42.62) | 2 (40.00) | 0 (0.00) | 26 (61.90) | 12 (57.14) | 7 (58.33) | 7 (77.78) | |
Notes: AMP Ampicillin, AMC Amoxicillin and Clavulafiate, CEP Cephalothin, CIP Ciprofloxacin, CTX Cefotaxime, DEC Diarrheagenic Escherichia coli, GEN Gentamicin, NAL Nalidixic acid, NTS Non–typhoideal Salmonella, REP Rifampicin, SXT Sulfamethoxazole–Trimethoprim, TCY Tetracycline
DEC has been classified into several subtypes based on mechanisms of pathogenicity and clinical feature, such as enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC), enterohemorrhagic E. coli (EHEC). NTS was discerned with serum agglutination test into S. enteritidis, S. enterica Typhimurium and other Salmonella
The comparison of the resistance of diarrheagenic Escherichia coli isolated from diarrhea cases and non–diarrhea subjects (age stratification)
| Antibiotics | All age groups | < 5 years | ≥ 5 years | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diarrhea | Control |
| Diarrhea | Control |
| Diarrhea | Control |
| ||||
| AMP | 100 (78.74) | 8 (88.89) | – | 0.294* | 78 (83.87) | 5 (100.00) | – | 0.428* | 22 (64.71) | 3 (75.00) | – | 0.405* |
| AMC | 47 (37.01) | 4 (44.44) | – | 0.245* | 33 (35.48) | 1 (20.00) | – | 0.318* | 14 (41.18) | 3 (75.00) | – | 0.194* |
| CEP | 38 (29.92) | 4 (44.44) | – | 0.184* | 33 (35.48) | 2 (40.00) | – | 0.348* | 5 (14.71) | 2 (50.00) | – | 0.132* |
| CTX | 23 (18.11) | 3 (33.33) | – | 0.166* | 21 (22.58) | 2 (40.00) | – | 0.252* | 2 (5.88) | 1 (25.00) | – | 0.266* |
| GEN | 39 (30.71) | 5 (55.56) | – | 0.091* | 29 (31.18) | 3 (60.00) | – | 0.157* | 10 (29.41) | 2 (50.00) | – | 0.291* |
| NAL | 65 (51.18) | 6 (66.67) | – | 0.187* | 52 (55.91) | 3 (60.00) | – | 0.349* | 13 (38.24) | 3 (75.00) | – | 0.167* |
| CIP | 7 (5.51) | 3 (33.33) | – |
| 6 (6.45) | 0 (0.00) | – | 0.724* | 1 (2.94) | 3 (75.00) | – |
|
| TCY | 88 (69.29) | 5 (55.56) | – | 0.192* | 64 (68.82) | 3 (60.00) | – | 0.328* | 24 (70.59) | 2 (50.00) | – | 0.291* |
| REP | 124 (97.64) | 9 (100.00) | – | 0.813* | 91 (97.85) | 5 (100.00) | – | 0.900* | 33 (97.06) | 4 (100.00) | – | 0.895* |
| SXT | 79 (62.20) | 5 (55.56) | – | 0.250* | 62 (66.67) | 2 (40.00) | – | 0.178* | 17 (50.00) | 3 (75.00) | – | 0.278* |
Notes: 1: AMP Ampicillin, AMCAmoxicillin and Clavulafiate, CEP Cephalothin, CTX Cefotaxime, GEN Gentamicin, NAL Nalidixic acid, CIP Ciprofloxacin, TCY Tetracycline, REP Rifampicin, SXT Sulfamethoxazole–Trimethoprim
2: The “–” means that the data cannot be calculated, the “*” means that the data was calculated with Fisher exact
3: The bold was showed there had significant difference between two groups
Fig. 1The molecular epidemiology of DEC and NTS strains isolated from subjects under five years of age. The PFGE pattern of DEC was discrete, but the pulsotype pattern of NTS strains were closely related to the serotype of NTS. The dendrogram was produced using the Dice coefficient and the UPGMA with a position tolerance of 1.0%; PFGE using XbaI endonuclease
Fig. 2The molecular epidemiology of DEC and NTS strains isolated from subjects over five years of age. The PFGE pattern of DEC was discrete, but the pulsotype pattern of NTS strains was closely related to the serotype of NTS. The dendrogram was produced using the Dice coefficient and the UPGMA with a position tolerance of 1.0%; PFGE using XbaI endonuclease